↓ Skip to main content

Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring

Overview of attention for article published in Drugs in R&D, May 2014
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter
1 X user

Citations

dimensions_citation
17 Dimensions

Readers on

mendeley
51 Mendeley
Title
Clinical Implications of the 2013 ESH/ESC Hypertension Guidelines: Targets, Choice of Therapy, and Blood Pressure Monitoring
Published in
Drugs in R&D, May 2014
DOI 10.1007/s40268-014-0049-5
Pubmed ID
Authors

Sverre E. Kjeldsen, Tonje A. Aksnes, Luis M. Ruilope

X Demographics

X Demographics

The data shown below were collected from the profile of 1 X user who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 51 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 1 2%
Unknown 50 98%

Demographic breakdown

Readers by professional status Count As %
Student > Master 12 24%
Researcher 6 12%
Student > Bachelor 5 10%
Student > Doctoral Student 4 8%
Student > Postgraduate 3 6%
Other 8 16%
Unknown 13 25%
Readers by discipline Count As %
Medicine and Dentistry 26 51%
Pharmacology, Toxicology and Pharmaceutical Science 6 12%
Nursing and Health Professions 2 4%
Biochemistry, Genetics and Molecular Biology 1 2%
Social Sciences 1 2%
Other 1 2%
Unknown 14 27%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 31 March 2016.
All research outputs
#15,365,885
of 22,858,915 outputs
Outputs from Drugs in R&D
#241
of 330 outputs
Outputs of similar age
#132,841
of 226,454 outputs
Outputs of similar age from Drugs in R&D
#6
of 9 outputs
Altmetric has tracked 22,858,915 research outputs across all sources so far. This one is in the 22nd percentile – i.e., 22% of other outputs scored the same or lower than it.
So far Altmetric has tracked 330 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 9.7. This one is in the 16th percentile – i.e., 16% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 226,454 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 31st percentile – i.e., 31% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 9 others from the same source and published within six weeks on either side of this one. This one has scored higher than 3 of them.